Product
Liposomal Mitoxantrone Hydrochloride
1 clinical trial
1 indication
Indication
Non-Hodgkin LymphomaClinical trial
Liposomal Mitoxantrone Hydrochloride, Gemcitabine, Vinorelbine With or Without Rituximab (GVM±R) in Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaStatus: Active (not recruiting), Estimated PCD: 2023-12-18